ReviewInternational journal of molecular sciences2022

Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.

Sara R Martins-Neves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.